CTT Pharmaceutical Holdings, Inc. (CTTH)
OTCMKTS · Delayed Price · Currency is USD
0.0790
-0.0001 (-0.15%)
May 4, 2026, 4:00 PM EST

CTTH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2014FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Dec '14 Feb '14
Selling, General & Admin
0.120.240.040.660.01
Amortization of Goodwill & Intangibles
0.010.01---
Operating Expenses
0.130.250.040.660.01
Operating Income
-0.13-0.25-0.04-0.66-0.01
Interest Expense
-0----
Other Non Operating Income (Expenses)
-0.03---0.01-0
Pretax Income
-0.16-0.25-0.04-0.67-0.02
Net Income
-0.16-0.25-0.04-0.67-0.02
Net Income to Common
-0.16-0.25-0.04-0.67-0.02
Shares Outstanding (Basic)
585251160
Shares Outstanding (Diluted)
585251160
Shares Change (YoY)
9.92%3.65%209.26%6435.55%-98.32%
EPS (Basic)
-0.00-0.00-0.00-0.04-0.07
EPS (Diluted)
-0.00-0.00-0.00-0.04-0.07
EBITDA
-0.12-0.24-0.04--
D&A For EBITDA
0.010.010.01--
EBIT
-0.13-0.25-0.04-0.66-0.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.